Navigation Links
Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event
Date:1/12/2011

PARSIPPANY, N.J., Jan. 12, 2011 /PRNewswire/ -- In 2011, what will be the major trends in the pharmaceutical industry?  What will drive innovation?  How will government regulations affect what's next and what's new?  What will the game changers be?  Who will survive in the competitive corporate landscape?  When it comes to market research, what's the smartest and most effective way to get the job done right? The answers to these questions and much more will be revealed at a pivotal, groundbreaking event - the Pharma Market Research Conference on February 1-2, in Parsippany, New Jersey.

The Pharma Market Research Conference is your EXCLUSIVE ENTRY into the world of pharmaceutical market research.  This is the most important and impactful event in pharmaceutical market research.  Nowhere else will you find the industry's best and brightest all under one roof!  

Located in the heart of New Jersey's Pharmaceutical Corridor, this event is an essential destination that shines a spotlight on the pharma industry for the world's most noteworthy market research executives.

The Pharma Market Research Conference's impressive advisory board includes senior-level thought leaders from Bayer, Eisai, Johnson & Johnson, Lundbeck, Merck, Pfizer, Purdue, Shire, and Takeda.  With their executive leadership, the Pharma Market Research Conference offers an intensive agenda for anyone wanting to network with and learn from the industry's best.

Talented speakers come from world class companies, including Abbott, Acorda Therapeutics, Alkermes, Allergan, AstraZeneca, Covidien, Daiichi Sankyo, Eisai, Johnson & Johnson, Lundbeck, Merck, Novartis, Pfizer, Roche, Shire, Takeda, ViroPharma & more!  For more about the speakers, go to: http://pharmamarketresearchconference.com/speakers

See what exciting innovations and solutions are being offered by 2011's premier sponsors/exhibitors, which include Ipsos Health, Segmedica, Affinnova, A+A Research, BioMedTracker, CBR Pharma Insights, ClarityQMR, Docnography, Dolcera, Drug Development Insights, Epocrates, Financial Times, Healogix, HRA Research, Life Science Analytics, ListenLogic, M3 Global Research, Medefield, MedPredict, Murray Hill Center, National Analysts Worldwide, Northern Light, Optimal Strategix, Reckner, The Research Partnership, Survey Sampling, Toluna, Truth On Call, Verilogue, and WorldOne.

The Pharma Market Research Conference only happens once a year.  More than 200 people came last time; 2011 is expected to be even bigger and better.  For more information or to register, call +1.212.228.7974 or go to: http://pharmamarketresearchconference.com/


'/>"/>
SOURCE Pharma Market Research Conference
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
Breaking Medicine News(10 mins):